期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
The Olfactory Receptor Pseudo-pseudogene: A Potential Therapeutic Target in Human Diseases 被引量:1
1
作者 CHEN Zhe HUANG Zhen CHEN Lin Xi 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2018年第2期168-170,共3页
Recently, Prieto-Godino et al.[1] found that the olfactory receptor 75a (Ir75a) gene is a functional pseudo-pseudogene in Drosophila sechellia. For a long time, Ir75a has been regarded as an acetic acid receptor tha... Recently, Prieto-Godino et al.[1] found that the olfactory receptor 75a (Ir75a) gene is a functional pseudo-pseudogene in Drosophila sechellia. For a long time, Ir75a has been regarded as an acetic acid receptor that detects acetic acid and induces obvious olfactory responses in olfactory sensory neurons (OSNs)f2J. Nonetheless, Prieto-Godino et al. confirmed that Ir75a lost its sensitivity to acetic acid in D. sechellia. Thus, the D. sechelfia Ir75a gene is generally recognized as a pseudogene in OSNs. 展开更多
关键词 PTC A potential Therapeutic Target in Human diseases The Olfactory Receptor Pseudo-pseudogene
下载PDF
The therapeutic potential of mesenchymal stem cells in Alzheimer's disease:converging mechanisms 被引量:3
2
作者 Gadi Turgeman 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第5期698-699,共2页
Mesenchymal stem cells (MSCS) are pluripotent stem cells isolated from various tissues, but mostly from bone marrow, adipose tissue, and umbilical cord blood. Well known for their mesenchymal lineages differentiati... Mesenchymal stem cells (MSCS) are pluripotent stem cells isolated from various tissues, but mostly from bone marrow, adipose tissue, and umbilical cord blood. Well known for their mesenchymal lineages differentiation (e.g., bone, cartilage and fat tissues), it was suggested that MSCs possess plasticity prop- erties enabling them to differentiate into non-mesenchymal lineages. Indeed, several protocols claimed for differentiating MSCs to neurons in vitro, but concern was raised for the ef- fectiveness and in vivo relevance of such differentiation. Thus, though their neurogenic differentiation properties are still in debate, they were nevertheless, suggested as candidates for treat- ing neurodegenerative disorders such as Parkinson's diseases, multiple sclerosis and Alzheimer's disease (AD). 展开更多
关键词 CELL STEM The therapeutic potential of mesenchymal stem cells in Alzheimer’s disease MSCS
下载PDF
Tetrahydrohyperforin(IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
3
作者 alexis gonzález viviana a.cavieres +1 位作者 nibaldo c.inestrosa patricia v.burgos 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第2期242-243,共2页
Alzheimer’s disease(AD)is the most common form of dementia worldwide among the older population.To date,there is no therapy to stop the destruction of brain cells and all the available treatments only compensate fo... Alzheimer’s disease(AD)is the most common form of dementia worldwide among the older population.To date,there is no therapy to stop the destruction of brain cells and all the available treatments only compensate for the loss of synaptic transmission,thus resulting in marginal benefits to patients. 展开更多
关键词 ERAD Tetrahydrohyperforin IDN5706 potential mechanism for Alzheimer’s disease therapy
下载PDF
Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
4
作者 Alba Di Pardo Vittorio Maglione 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第9期1439-1440,共2页
Huntington's disease (HD) is the most common dominantly inherited neurodegenerative disorder, mainly characterized by the progressive striatal and cortical neurodegeneration and as- sociated motor, cognitive and be... Huntington's disease (HD) is the most common dominantly inherited neurodegenerative disorder, mainly characterized by the progressive striatal and cortical neurodegeneration and as- sociated motor, cognitive and behavioural disturbances (Zuccato et al., 2010). The disease-causing mutation is an expansion of a GAG trinucleotide repeat (〉 36 repeats) encoding a polygluta- mine stretch in the N-terminal region ofhuntingtin (Htt) (Zuc- cato et al., 2010), a ubiquitous protein whose function is still unclear (Zuccato et al., 2010). Expansion of the polyQ stretch endows mutant Htt (mHtt) with toxic properties, and results in the development of a broad array of undesirable effects in both neuronal and non-neuronal cells (Zuccato et al., 2010). Among all cellular dysfunctions and biochemical imbalances classically associated with HD, perturbed metabolism of (glyco) sphingolipids appears to play a crucial role in the pathogenesis of the disease. Over the last years, we and other have extensively contributed to these findings (Desplats et al., 2007; 展开更多
关键词 Glyco-sphingo biology a novel perspective for potential new treatments in Huntington’s disease HD
下载PDF
SLP-2: a potential new target for improving mitochondrial function in Parkinson's disease
5
作者 Alessandra Zanon Andrew A.Hicks +1 位作者 Peter P.Pramstaller Irene Pichler 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第9期1435-1436,共2页
Parkinson's disease (PD) is a progressive neurodegenerative disease, which is generally considered a multifactorial disorder that arises owing to a combination of genes and environmental factors. While most cases a... Parkinson's disease (PD) is a progressive neurodegenerative disease, which is generally considered a multifactorial disorder that arises owing to a combination of genes and environmental factors. While most cases are idiopathic, in about 10% of the patients a genetic cause can be detected, ascribable to mutations in more than a dozen genes. PD is characterized clinically by tremor, rigidity, reduced mo- tor activity (bradykinesia), and postural instability and pathological- ly by loss of dopaminergic (DA) neurons in the substantia nigra pars compacta, loss of DA innervation in the striatum, and the presence of a-synuclein positive aggregates in the form of Lewy bodies. The symptomatic treatment of PD with levodopa, which aims at replac- ing dopamine, remains the gold standard, and no neuroprotective or disease-modifying therapy is available. During treatment, the disease continues to progress, and long-term use of levodopa has import- ant limitations including motor complications termed dyskinesias. Therefore, a pharmacological therapy able to prevent or halt the neu- rodegenerative process is urgently required. 展开更多
关键词 SLP-2 a potential new target for improving mitochondrial function in Parkinson’s disease
下载PDF
The Mitochondrion:A Potential Therapeutic Target for Alzheimer's Disease 被引量:4
6
作者 Mei-Hong Lu Xiu-Yun Zhao +2 位作者 Pei-Pei Yao De-En Xu Quan-Hong Ma 《Neuroscience Bulletin》 SCIE CAS CSCD 2018年第6期1127-1130,共4页
Introduction The mitochondrion is a double-membrane organelle consisting of an outer membrane, intermembrane space, inner membrane, cristae, and matrix. It is the ‘‘energy plant’’ that provides most of the energy ... Introduction The mitochondrion is a double-membrane organelle consisting of an outer membrane, intermembrane space, inner membrane, cristae, and matrix. It is the ‘‘energy plant’’ that provides most of the energy for cells. Mitochondria also participate in various processes such as calcium homeosta- 展开更多
关键词 AD A potential Therapeutic Target for Alzheimer’s Disease
原文传递
Burden of injuries and diseases in Yunnan Tin Miners
7
作者 TimothyD.BAKER QIAOYoulin YAOShuxiang 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第6期957-958,共2页
The burden of injuries is underestimated to an evengreater extent in developing countries than inindustrialized countries. The objective of this paper is toanalyze injuries and diseases in the monitored work place
关键词 burden of diseases· burden of injures·potential productive years of life lost·radon arsenic·lung cancer
原文传递
Burden of traffic accidents among pedestrians of Fars province, southern Iran; estimate of years of life lost in a sample of Iranian population from 2009 to 2013 被引量:1
8
作者 Yaser Sarikhani Seyed Taghi Heydari +6 位作者 Saeed Gholamzadeh Maryam Mazloom Payam Peymani Kamran Bagheri Lankarani Ahmad Kalateh Sadati Reza Tabrizi Maryam Akbari 《Chinese Journal of Traumatology》 CAS CSCD 2017年第5期259-263,共5页
Purpose: Traffic injuries are among the leading causes of mortality and morbidity worldwide. Pedestrians have been considered as a high-risk group among road users, especially in middle- or low-income communities. Th... Purpose: Traffic injuries are among the leading causes of mortality and morbidity worldwide. Pedestrians have been considered as a high-risk group among road users, especially in middle- or low-income communities. This study attempted to determine the burden of pedestrians' fatalities in Fars, the southern province of Iran using years of life lost (YLL) approach. Methods: The data used in this study were retrieved from Fars Forensic Medicine Organization database on pedestrian traffic accidents. The YLL from 2009 to 2013 was estimated using the method presented by World Health organization. Some epidemiological characteristics of pedestrians' fatalities were analyzed by SPSS. Results: Although YLL among 1000 male pedestrians decreased from 2.5 in 2009 to 1.5 in 2013, it increased from 0.9 to 2.1 among 1000 females during the same period. Higher proportion of death was found in female, illiterate, and married pedestrians {p 〈 0.001 ). In addition, mortality was higher in pedestrians living the cities, during daytime, at home, and in hospitals (p 〈 0.001 ). Conclusion: Consistent with the global trends, burden of pedestrian accidents in Fats was also excep- tionally high. Considering the national and cultural aspects of different countries, improving the safety of pedestrians demands a multi-dimensional approach with interventional factors concerning policies, rules, pedestrians, motor vehicles and environmental conditions taken into consideration. 展开更多
关键词 Accidents traffic Pedestrians Burden of disease Years of potential life lost
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部